Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | |
---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||
Cash from operating activities | 12.82%299.96M | -34.44%265.87M | 99.80%405.55M | 8.29%202.98M | 427.66%187.44M | -57.21M |
Net profit before non-cash adjustment | -26.37%252.36M | -1.70%342.71M | 99.86%348.65M | 465.17%174.44M | -54.12%30.87M | --67.28M |
Total adjustment of non-cash items | 84.06%-4.61M | -136.34%-28.93M | 89.25%79.6M | -29.61%42.06M | 2,791.58%59.75M | ---2.22M |
-Depreciation and amortization | -9.06%17.6M | -4.14%19.36M | 12.97%20.19M | 20.05%17.87M | 107.20%14.89M | --7.19M |
-Reversal of impairment losses recognized in profit and loss | --0 | --11.88M | --0 | ---- | ---- | --15.86M |
-Disposal profit | --2.49M | --0 | ---- | ---- | ---- | ---- |
-Other non-cash items | 58.94%-24.71M | -201.28%-60.16M | 145.62%59.41M | -46.09%24.19M | 277.61%44.87M | ---25.26M |
Changes in working capital | 208.97%52.22M | -111.13%-47.92M | -67.85%-22.7M | -113.96%-13.52M | 179.19%96.82M | ---122.26M |
-Change in receivables | 54.89%-93.85M | -206.43%-208.06M | -147.06%-67.9M | 42.16%144.28M | 154.84%101.49M | ---185.08M |
-Change in inventory | 180.64%4.65M | -31,927.78%-5.77M | -100.21%-18K | 882.36%8.74M | -95.65%890K | --20.48M |
-Change in prepaid assets | ---- | ---- | 89.76%-12.46M | -174.60%-121.66M | -199.57%-44.31M | --44.5M |
-Change in payables | 28.16%165.17M | 174.82%128.88M | 216.53%46.9M | -203.86%-40.24M | 5,329.01%38.75M | ---741K |
-Provision for loans, leases and other losses | -628.42%-2.94M | 128.53%556K | 54.08%-1.95M | -308.24%-4.24M | 244.54%2.04M | ---1.41M |
-Changes in other current assets | -157.09%-20.82M | 186.50%36.47M | 3,330.71%12.73M | 80.67%-394K | ---2.04M | ---- |
Dividends paid (cash flow from operating activities) | ||||||
Dividends received (cash flow from operating activities) | ||||||
Interest paid (cash flow from operating activities) | 62.82%-174K | 57.06%-468K | 47.65%-1.09M | -10.51%-2.08M | -91.85%-1.88M | -982K |
Interest received (cash flow from operating activities) | -8.70%21K | 43.75%23K | 220.00%16K | 66.67%5K | 50.00%3K | 2K |
Tax refund paid | 72.19%-47.43M | -158.02%-170.59M | -260.88%-66.11M | -68.41%-18.32M | -202.42%-10.88M | -3.6M |
Other operating cash inflow (outflow) | 0 | -1K | 0 | 0 | 99.97%-1K | -3.13M |
Operating cash flow | 166.11%252.37M | -71.97%94.84M | 85.32%338.36M | 4.52%182.59M | 369.12%174.68M | ---64.91M |
Investing cash flow | ||||||
Net PPE purchase and sale | -1,593.28%-68.56M | 50.16%-4.05M | -195.74%-8.12M | -64.79%-2.75M | 97.93%-1.67M | ---80.66M |
Net intangibles purchase and sale | ---- | ---- | 96.10%-704K | -141.81%-18.06M | ---7.47M | ---- |
Net investment product transactions | --0 | ---41.64M | --0 | ---- | ---- | ---- |
Advance cash and loans provided to other parties | -137.65%-1.36M | ---571K | --0 | ---- | ---- | ---- |
Net changes in other investments | -4,933.83%-36.9M | 2.40%-733K | -142.26%-751K | 92.89%-310K | 93.53%-4.36M | ---67.43M |
Investing cash flow | -127.32%-106.82M | -390.54%-46.99M | 54.63%-9.58M | -56.45%-21.12M | 90.89%-13.5M | ---148.08M |
Financing cash flow | ||||||
Net issuance payments of debt | --0 | 17.06%-94.45M | 14.59%-113.88M | -318.19%-133.33M | -78.22%61.11M | --280.55M |
Net common stock issuance | -12,081.61%-228.01M | -99.87%1.9M | 4,210.06%1.5B | --34.88M | ---- | ---- |
Increase or decrease of lease financing | 187.67%1.15M | 23.16%-1.31M | -4.01%-1.71M | -3.53%-1.64M | -16.68%-1.59M | ---1.36M |
Issuance fees | ---- | ---- | ---5.61M | ---- | ---- | ---- |
Net other fund-raising expenses | 199.84%85.28M | -4,270,700.00%-85.42M | ---2K | ---- | 32,000.00%319K | ---1K |
Financing cash flow | 21.03%-141.58M | -112.97%-179.28M | 1,480.54%1.38B | -267.28%-100.1M | -78.57%59.84M | --279.19M |
Net cash flow | ||||||
Beginning cash position | -5.58%2.22B | 265.03%2.36B | 10.51%645.49M | 60.87%584.12M | 22.30%363.09M | --296.9M |
Current changes in cash | 103.03%3.98M | -107.68%-131.43M | 2,687.60%1.71B | -72.23%61.37M | 233.89%221.03M | --66.2M |
Cash adjustments other than cash changes | ---- | -200.00%-1K | 200.00%1K | ---1K | ---- | ---- |
End cash Position | 0.18%2.23B | -5.58%2.22B | 265.03%2.36B | 10.51%645.49M | 60.87%584.12M | --363.09M |
Free cash flow | 102.46%183.81M | -72.45%90.79M | 103.69%329.54M | -2.28%161.78M | 213.72%165.55M | ---145.57M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |